Axcelis Technologies (ACLS) Tops Q2 EPS by 33c
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 11/4/2026
- Wall Street ends higher after Democrats win Congress; data center stocks tumble
- What the Democratic sweep in the midterms means for markets
- SpaceX, Tesla slide as election risks mount, Morgan Stanley turns bullish
- CVS Health plans to split into two public companies by 2028
- AI sector outlook darkens as Democrat wins threaten $900B capex cycle
Tweet
Share
E-mail
Get Alerts ACLS Hot Sheet
Price: $91.29 -6.25%
Revenue Growth %: +0.5%
Financial Fact:
General and administrative: 5.99M
Today's EPS Names:
ATS, SICP, FTCO, More
Revenue Growth %: +0.5%
Financial Fact:
General and administrative: 5.99M
Today's EPS Names:
ATS, SICP, FTCO, More
Join SI Premium – FREE
Axcelis Technologies (NASDAQ: ACLS) reported Q2 EPS of $1.32, $0.33 better than the analyst estimate of $0.99. Revenue for the quarter came in at $221.2 million versus the consensus estimate of $210.64 million.
GUIDANCE:
Axcelis Technologies sees Q3 2022 EPS of $1.10-$1.15, versus the consensus of $1.07. Axcelis Technologies sees Q3 2022 revenue of $220-228 million, versus the consensus of $217 million.
For earnings history and earnings-related data on Axcelis Technologies (ACLS) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Arm Holdings (ARM) Tops Q2 EPS by 5c, Beats on Revenue; Offers Q3 Guidance
- Harmony Biosciences (HRMY) Misses Q3 EPS by 30c; Offers Guidance
- Global Indemnity (GBLI) Misses Q3 EPS by 12c
Create E-mail Alert Related Categories
Earnings, GuidanceRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
